Search - tctmd.com

Displaying 921 - 940 of 4092

Sort: Relevancy | Date

News Daily News

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

Michael O'Riordan

May 04, 2022

News Daily News

For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains

Michael O'Riordan

May 03, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2022

Shelley Wood

May 02, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

The NCDR Has Made a Difference, but Experts See Room for Growth

Todd Neale

April 28, 2022

News Daily News

FDA Proposes Ban on Menthol Cigarettes and Flavored Cigars

Michael O'Riordan

April 28, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Daily News

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Michael O'Riordan

April 25, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

Podcast TCTMD Talking Points

MASTER DAPT: High-Risk Patients

April 20, 2022

News Daily News

Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock

Caitlin E. Cox

April 18, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

News Conference News ACC 2022

METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF

Todd Neale

April 08, 2022

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

Presentation ACC 2022

The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic Heart Failure And Reduced Ejection Fraction: METEORIC-HF

Presenter: Michael Felker

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

Advertisement

Age and Fitness Biggest Predictors of Mortality in CAD Patients, AI Study Shows

For Coronary Heart Disease, Upping Exercise Over Time Linked to Survival Gains

TCTMD’s Top 10 Most Popular Stories for April 2022

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

The NCDR Has Made a Difference, but Experts See Room for Growth

FDA Proposes Ban on Menthol Cigarettes and Flavored Cigars

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

MASTER DAPT: High-Risk Patients

Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Managing AF Patients Undergoing PCI—Some Lingering Questions

METEORIC-HF: Omecamtiv Mecarbil Doesn’t Boost Exercise Capacity in HFrEF

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

The Effect Of Omecamtiv Mecarbil On Exercise Tolerance In Patients With Chronic Heart Failure And Reduced Ejection Fraction: METEORIC-HF

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content